STAT Plus: Private insurance might provide some shield from insulin price hikes — but the picture of costs is complicated
ADOBE
Research suggests private insurance might provide some shield against insulin price hikes, but insurers may deal with increases by raising other costs.
.png)
No hay comentarios:
Publicar un comentario